CABA
Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present
Board Member
Cabaletta Bio, Inc. (CABA)Equibles does not estimate personal net worth.
Get an email with a short summary when Cabaletta Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get CABA alertsSteven Nichtberger is recorded as Board Member at Cabaletta Bio, Inc. (CABA) since January 1, 2017 and CEO at Cabaletta Bio, Inc. (CABA). The newest filing on record that lists Steven Nichtberger as CEO and Board Member at Cabaletta Bio, Inc. (CABA) is dated April 28, 2026. Steven Nichtberger has spoken on 2 investor events across 1 company, most recently for Cabaletta Bio, Inc. on September 16, 2026. Cabaletta Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cabaletta Bio, Inc. includes Anup Marda (CFO), Michael Gerard (General Counsel), Scott Brun (Board Member) and 3 others.
“So, listen, patients who have autoimmune disease simply want to get rid of their symptoms, get rid of their medicines, and just be normal people. They don't want to have the patient label.”
“So, listen, patients who have autoimmune disease simply want to get rid of their symptoms, get rid of their medicines, and just be normal people. They don't want to have the patient label.”
2017-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
CABA
Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present